Beacon Financial Advisory LLC Iovance Biotherapeutics, Inc. Transaction History
Beacon Financial Advisory LLC
- $280 Million
- Q4 2024
A detailed history of Beacon Financial Advisory LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Beacon Financial Advisory LLC holds 20,560 shares of IOVA stock, worth $125,415. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,560
Previous 21,120
2.65%
Holding current value
$125,415
Previous $198,000
23.23%
% of portfolio
0.05%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding IOVA
# of Institutions
318Shares Held
244MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$167 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$162 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$146 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$129 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$80.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $963M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...